Bayesian Capital Management, LP Amyris, Inc. Transaction History

Bayesian Capital Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.09 - $1.82 $81,968 - $136,864	75,200 New	75,200 $102,000
Q3 2022 Nov 14, 2022	BUY	$1.7 - $4.05 $74,536 - $177,572	43,845 New	43,845 $128,000
Q2 2022 Aug 15, 2022	SELL	$1.6 - $5.07 $83,040 - $263,133	-51,900 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$3.92 - $5.86 $203,448 - $304,134	51,900 New	51,900 $226,000
Q2 2019 Aug 13, 2019	SELL	$2.07 - $5.12 $64,790 - $160,256	-31,300 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$1.88 - $5.7 $58,844 - $178,410	31,300 New	31,300 $65,000
Q3 2018 Nov 14, 2018	SELL	$6.12 - $8.97 $74,664 - $109,434	-12,200 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$5.03 - $7.06 $5,030 - $7,060	-1,000 Reduced 7.58%	12,200 $78,000
Q1 2018 May 15, 2018	BUY	$4.02 - $6.81 $53,063 - $89,892	13,200 New	13,200 $88,000

230K

Ticker AMRS
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 324,860,000
Market Cap $3.25M
Description
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.